Good morning :)
Place Order
Add to Watchlist

Biocon Ltd

BIOCON

Biocon Ltd

BIOCON
Health CareBiotechnology
MidcapWith a market cap of ₹32,786 cr, stock is ranked 222
High RiskStock is 3.11x as volatile as Nifty
274.001.55% (-4.30)
274.001.55% (-4.30)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareBiotechnology
MidcapWith a market cap of ₹32,786 cr, stock is ranked 222
High RiskStock is 3.11x as volatile as Nifty

How to use scorecard? Learn more

Health CareBiotechnology
MidcapWith a market cap of ₹32,786 cr, stock is ranked 222
High RiskStock is 3.11x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
27.321.460.55%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.965.950.56%

Forecast & Ratings

Detailed Forecast 
56%
Analysts have suggested that investors can buy this stock

from 16 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Biocon Limited is a biopharmaceutical company engaged in the research & development and manufacture of pharmaceuticals, medicinal chemical and botanical products.

Investor Presentation

View older 

Aug 11, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 21.56%, vs industry avg of 19.45%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 84.32% to 92.03%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 4.44%, vs industry avg of 8.68%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue3,277.703,716.704,064.504,350.905,854.306,529.407,410.208,396.7011,550.1015,605.50
Raw Materialssubtract1,308.001,330.901,515.601,677.802,106.302,190.302,533.802,975.003,817.2011,381.00
Power & Fuel Costsubtract176.70184.70156.40189.00239.80246.10270.30316.40414.80
Employee Costsubtract567.20610.10747.00931.101,165.301,458.801,741.001,880.102,181.00
Selling & Administrative Expensessubtract470.10524.50540.10519.30846.70952.701,041.701,158.101,338.60
Operating & Other expensessubtract-98.3037.20-47.50-22.90-237.40-121.60-17.10202.201,369.30
Depreciation/Amortizationsubtract221.00248.70277.20385.10447.80552.20715.10814.201,113.101,525.50
Interest & Other Itemssubtract8.9029.3026.0061.5070.9064.9057.7067.60419.00996.20
Taxes & Other Itemssubtract126.70200.90237.60237.60309.60437.80327.20334.70434.40502.60
EPS4.144.595.103.107.546.236.175.403.8510.00
DPS0.830.830.500.500.500.000.000.501.501.50
Payout ratio0.200.180.100.160.070.000.000.090.390.15

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

Apr 29PDF
Apr 28PDF
Mar 1PDF
+2 more
FY 2023

Annual report

PDF

Investor Presentation

May 24PDF
Feb 17PDF
Nov 15PDF
Jul 27PDF
FY 2024

Annual Report Pending

Investor Presentation

Aug 11PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareBiotechnology

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Biocon Ltd70.861.460.55%
Hester Biosciences Ltd51.094.710.50%
Panacea Biotec Ltd-26.571.05
Zenotech Laboratories Ltd36.025.07

Price Comparison

Compare BIOCON with any stock or ETF
Compare BIOCON with any stock or ETF
BIOCON
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.41%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding60.64%9.31%5.20%6.55%18.30%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '2315.79%14.42%10.20%9.52%7.96%6.55%

Mutual Funds Holding Trend

Increased Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.05%

Top 5 Mutual Funds holding Biocon Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI CONTRA FUND DIRECT PL GROWTH

Growth
1.3512%1.65%-0.29%12/106 (-5)
Mirae Asset Large Cap Fund - Growth - Direct Plan

Growth
0.8467%0.73%-0.06%42/76 (+7)
SBI Balanced Advantage Fund - Direct Growth

Growth
0.8074%0.92%-0.03%75/123 (-5)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 7, 2023

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Jul 7, 2023

Cash Dividend

Ex DateEx DateJun 30, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jun 30, 2022

Cash Dividend

Ex DateEx DateJul 18, 2019

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 18, 2019

Cash Dividend

Ex DateEx DateJul 19, 2018

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Jul 19, 2018

Cash Dividend

Ex DateEx DateJul 20, 2017

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Jul 20, 2017